Page last updated: 2024-10-30

ketotifen and Keratoconjunctivitis

ketotifen has been researched along with Keratoconjunctivitis in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.

Research Excerpts

ExcerptRelevanceReference
"To report the effect of topically applied ketotifen fumarate in the treatment of superior limbic keratoconjunctivitis (SLK)."7.71Ketotifen fumarate treatment of superior limbic keratoconjunctivitis. ( Guidera, AC; Madani-Becker, J; Udell, IJ, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Udell, IJ1
Guidera, AC1
Madani-Becker, J1

Other Studies

1 other study available for ketotifen and Keratoconjunctivitis

ArticleYear
Ketotifen fumarate treatment of superior limbic keratoconjunctivitis.
    Cornea, 2002, Volume: 21, Issue:8

    Topics: Administration, Topical; Aged; Conjunctiva; Female; Histamine H1 Antagonists; Humans; Keratoconjunct

2002